Engineered bone marrow as a clinically relevant ex vivo model for primary bone cancer research and drug screening

Proceedings of the National Academy of Sciences, Volume 120, Issue 39, September 2023.
>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : National Academy of Sciences – https://www.pnas.org/doi/abs/10.1073/pnas.2302101120?af=R

Exit mobile version